• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

5.325 +0.084 (+1.61%)
Delayed Quote Updated: 3:58 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Researchers in South Korea Identify New Protein That Controls Brain Cancer Growth
September 28, 2026
Via Investor Brand Network
Injectable Nanodevices Exhibit Potency Against Brain Tumors
September 21, 2026
Via Investor Brand Network
Accelerated Biological Aging Could Explain Why Younger Adults are Getting Cancer
September 17, 2026
Via Investor Brand Network
Laser Therapy Shows Promise in Treating Brain Cancer
September 08, 2026
Via Investor Brand Network
Timing of Brain Metastasis Predicts Survival of Colorectal Cancer Patients
September 04, 2026
Via Investor Brand Network
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Business Development Strategy in Virtual Investor Segment
September 01, 2026
Via Investor Brand Network
New T Cell Therapy Could Transform Glioblastoma Care
August 24, 2026
Via Investor Brand Network
Collagen Tiles Could Prevent Brain Cancer Recurrence
June 08, 2026
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
September 01, 2026
From CNS Pharmaceuticals, Inc.
Via ACCESS Newswire
Covid-19 Vaccine Could Extend Survival of Brain Cancer Patients
August 27, 2026
Via Investor Brand Network
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Strategic Transformation at Virtual Investor Conference
August 27, 2026
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
August 27, 2026
From CNS Pharmaceuticals, Inc.
Via ACCESS Newswire
Researchers Identify a Protein That Could Be Targeted in Glioblastoma Therapy
August 18, 2026
Via Investor Brand Network
NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 Results as Strategic Pivot Advances
August 12, 2026
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
August 12, 2026
From CNS Pharmaceuticals, Inc.
Via ACCESS Newswire
Focused Ultrasound Shows Promise in Treating Brain Tumors
August 10, 2026
Via Investor Brand Network
Spanish Patient Highlights Risks of Poorly Cooked Pork
August 07, 2026
Via Investor Brand Network
Novel Vitamin B12 Treatment Offers Hope in Brain Cancer Treatment
July 30, 2026
Via Investor Brand Network
Experimental Immunotherapy Offers Hope Against Deadly Pediatric Brain Cancer
July 27, 2026
Via Investor Brand Network
Study Finds No Evidence That Mobile Phones Can Cause Brain Cancer
July 21, 2026
Via Investor Brand Network
Widely Prescribed Thyroid Hormone Could Prevent Pediatric Brain Tumor Recurrence
July 13, 2026
Via Investor Brand Network
New Vaccine Gives Brain Cancer Patients Hope of Longer Survival
July 10, 2026
Via Investor Brand Network
Scientists Find Targeting Enzyme That Could Block Brain Metastases
June 24, 2026
Via Investor Brand Network
WashU Vaccine Could Revolutionize Personalized Glioblastoma Treatment
June 23, 2026
Via Investor Brand Network
Study Links TBI to Higher Mortality Risk Due to Brain Cancer
June 12, 2026
Via Investor Brand Network
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Oversubscribed $22.5 Million Financing and Growth Strategy in Investor Presentation
June 08, 2026
Via Investor Brand Network
News headline image
CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment
June 08, 2026
Via ACCESS Newswire
Pediatric Brain Tumors Spread Faster as Immune Cells Build Enabling Scaffolding
June 04, 2026
Via Investor Brand Network
Study Finds Many Young Adults Suffer Sexual Problems After Cancer Treatment
May 27, 2026
Via Investor Brand Network
Study Finds Many Young Adults Suffer Sexual Problems After Cancer Treatment
May 26, 2026
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap